Pulmonary arterial hypertension
RecruitingStudy comparing tadalafil with ambrisentan versus tadalafil alone in newly diagnosed patients with pulmonary arterial hypertension who have cardiovascular conditions
Study comparing tadalafil with ambrisentan versus tadalafil alone in newly diagnosed patients with pulmonary arterial hypertension who have cardiovascular conditions
- Disease:Pulmonary arterial hypertension
- Substances:AmbrisentanTadalafil
France- Participants:18–64 years · 65+ years
- Substances:Ambrisentan
- Sponsor:Assistance Publique Hopitaux De Paris









